Parallel trade: are industry concerns real or imagined?
Authors
Abstract
The parallel trade in medicines is claimed to save money for the NHS, but results in lost profits for the pharmaceutical industry. Here, Steve Chaplin examines the pros and cons of parallel imports. Copyright © 2006 Wiley Interface Ltd
Digital Object Identifier (DOI)
10.1002/psb.413 About DOI
Login/Logout
Journal Menu
- Home
- News
- Current Issue
- Archive Issues
- Learning Central
- Ask Prescriber
- Prescriber Blog
- Forthcoming Events
- Supplements
- Wiley Job Network
Advertising and Sponsorship
Other Journals
